News

Laidlaw Venture Partners Hosts Panel Discussion “Cutting Edge Perspectives on the Latest Developments in COVID-19 Vaccine Development Strategy”

Laidlaw Venture Partners Hosts Panel Discussion “Cutting Edge Perspectives on the Latest Developments in COVID-19 Vaccine Development Strategy” Featuring Michael V. Callahan, MD, MSPH, DTM&H (U.K), Massachusetts General Hospital (MGH) Infectious Disease and Director, [...]

August 25th, 2020|Categories: News, press release|

Voltron Therapeutics, Inc. Initiates Animal Testing of Self-Assembling Vaccine in Fight Against COVID-19

Voltron Therapeutics, Inc. Initiates Animal Testing of Self-Assembling Vaccine in Fight Against COVID-19 Animal Trials to Assess the Effect of Novel Vaccine HaloVax™ Against COVID-19 July 08, 2020 08:30 ET [...]

July 9th, 2020|Categories: News, press release|

Voltron Therapeutics Retains Buenaventura Advisors, LLC to Explore Strategic Alternatives for its HaloVax™ Subsidiary

Voltron Therapeutics Retains Buenaventura Advisors, LLC to Explore Strategic Alternatives for its HaloVax™ Subsidiary Unique, Self-Assembling Vaccine Against COVID-19 is in Animal Testing July 09, 2020 09:25 ET | Source: [...]

July 9th, 2020|Categories: News, press release|

Voltron Therapeutics, Inc. Enters into Sponsored Research Agreement with The Vaccine & Immunotherapy Center at the Massachusetts General Hospital to Advance the Development of a Personalized Cancer Vaccine
Voltron Therapeutics, Inc. Enters into Sponsored Research Agreement with The Vaccine & Immunotherapy Center at the Massachusetts General Hospital to Advance the Development of a Personalized Cancer Vaccine

News, press release

Voltron Therapeutics, Inc. Enters into Sponsored Research Agreement with The Vaccine & Immunotherapy Center at the Massachusetts General Hospital to Advance the Development of a Personalized Cancer Vaccine

Voltron Therapeutics, Inc. Enters into Sponsored Research Agreement with The Vaccine & Immunotherapy Center at the Massachusetts General Hospital to Advance the Development of a Personalized Cancer Vaccine Collaboration will continue animal testing of [...]

June 11th, 2020|Categories: News, press release|